6-hydroxynorketamine has been researched along with Depression, Involutional in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browne, CA; Lucki, I; Wulf, HA; Zarate, CA | 1 |
| Burke, AK; Choo, TH; Cooper, TB; Galfalvy, HC; Grunebaum, MF; Mann, JJ; Parris, MS; Suckow, RF | 1 |
| Elmer, GI; Gould, TD; Mayo, CL; Tapocik, JD; Zanos, P | 1 |
| Aguilar-Valles, A; Bermudez, S; De Gregorio, D; Eslamizade, MJ; Gobbi, G; Khlaifia, A; Lacaille, JC; Lopez-Canul, M; Matta-Camacho, E; Rurak, GM; Salmaso, N; Simard, S; Skaleka, A; Sonenberg, N; Torres-Berrio, A | 1 |
1 trial(s) available for 6-hydroxynorketamine and Depression, Involutional
| Article | Year |
|---|---|
Ketamine metabolite pilot study in a suicidal depression trial.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Infusions, Parenteral; Ketamine; Midazolam; Outcome Assessment, Health Care; Pilot Projects; Severity of Illness Index; Suicidal Ideation | 2019 |
3 other study(ies) available for 6-hydroxynorketamine and Depression, Involutional
| Article | Year |
|---|---|
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors.
Topics: Animals; Behavior, Animal; Depressive Disorder, Major; Humans; Ketamine; Mice; Naltrexone; Receptors, Opioid, kappa | 2022 |
Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma.
Topics: Animals; Behavior, Animal; Depressive Disorder, Major; Female; Ketamine; Male; Mice; Mice, Inbred C57BL; Predatory Behavior; Stress, Psychological | 2020 |
Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antidepressive Agents; Cell Cycle Proteins; Depressive Disorder, Major; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factors; Excitatory Postsynaptic Potentials; Hippocampus; Inhibitory Postsynaptic Potentials; Interneurons; Ketamine; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mutation; Neural Inhibition; Neurons; Protein Biosynthesis; Pyramidal Cells; Synaptic Transmission | 2021 |